DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
![Heart vs money-GettyImages-1055238506]( "Can DCTs Be Both Patient Centric And Financially Efficient For Sites?")
Can DCTs Be Both Patient Centric And Financially Efficient For Sites?While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.
-
![People getting covid vaccine GettyImages-1337773066]( "Advancing Rare Disease Research With Patient Registries")
Advancing Rare Disease Research With Patient RegistriesIn this Q&A, “Rare dad” Harsha Rajasimha, Ph.D. of IndoUSrare discusses the current state of rare disease research and explains how patient registries can help propel drug development for rare disease therapies.
DCT TECHNOLOGY VIDEOS
Seize the opportunity to elevate your approach to DCTs by watching this presentation on the importance of adopting a fully unified EDC/CDMS to alleviate the burdens on users, sites, and patients.
Explore how data-driven strategies and innovative, user-friendly integration tools are forging stronger connections with patients, ensuring consistent data flows, and accelerating the generation of insights.
Castor joins experts from United Biosource (UBC) and Datavant to discuss all things real-world evidence, patient-centric technologies, and the role of tokenization in clinical research.
Watch three short videos discussing how to achieve success in decentralized clinical trials from the patient, sponsor, and site perspectives to improve DCT outcomes.
DCT TECHNOLOGY RESOURCES
-
![GettyImages-1447084050 data]( "Gradually Investing In Direct Data Capture Is Inevitable")
Given study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”
-
![GettyImages-1337453095-doctor-patient]( "Direct-From-Patient Data Capture With eCOA")
Learn how an eCOA tool can provide patients a chance to be heard while giving sponsors quantitative and qualitative data to track the efficacy of a treatment.
-
![GettyImages-1355941377 source data]( "Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC")
Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.
-
![GettyImages-1302453801 trial design ps]( "Considerations For Implementing The Best eCOAs In Your Trial Design")
Dive into considerations when deciding on the best COAs to implement as well as best practices when developing your eCOA strategy in this blog.
-
![GettyImages-1311429557-vaccine-shot]( "eTMF Systems Tell Compelling Story Of COVID-19 Vaccines")
The rapid development of Covid-19 vaccines may lead more drug developers to increase their speed and agility by adopting electronic Trial Master File (eTMF) systems. In the case of Covid-19 vaccines, discover how eTMF systems tell a dramatic tale.
-
![Interview-with-Scott-Merz]( "Interview Mode: A Valuable Data Collection Alternative Supporting Decentralized Clinical Trials")
Download the available infographic to discover how collecting ePRO & eObsRO data via interview mode can be recommended in specific circumstances.
-
![GettyImages-1403114912 oncology patient]( "What’s Missing From Decentralized Trials? The Human Element")
DCTs are complex, and disconnects between sites and solution providers are common. However, a dedicated site management team improves relationships between providers and sites to maximize DCTs’ value.
